` ALID (Allied Corp) vs S&P 500 Comparison - Alpha Spread

A
ALID
vs
S&P 500

Over the past 12 months, ALID has underperformed S&P 500, delivering a return of -99% compared to the S&P 500's +13% growth.

Stocks Performance
ALID vs S&P 500

Loading
ALID
S&P 500
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ALID vs S&P 500

Performance Gap Between ALID and GSPC
HIDDEN
Show

Performance By Year
ALID vs S&P 500

Loading
ALID
S&P 500
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Allied Corp vs Peers

No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Allied Corp
Glance View

Market Cap
57.8k USD
Industry
Pharmaceuticals

Allied Corp. operates as a medical cannabis company. The company is headquartered in Kelowna, British Columbia. The company went IPO on 2018-12-04. The firm is focused on creating and providing health solutions to address medical mental health issues. The firm focuses to discover medical technologies, which are cannabis derived to target full scope therapy and support for trauma survivors, military veterans and first responders. Its functional mushroom formulation targets major depression and anxiety. The firm is also engaged in research and development activities in the psilocybin space and holds formulations.

ALID Intrinsic Value
Not Available
Back to Top